Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • c_ro87
    Member
    • Feb 2012
    • 12

    #1

    Help with a probably bad variant call

    Hello all,

    i have a variant from a ION PGM sequencing, called with the ION Torrent variant caller plugin

    CHR POS ID REF ALT

    chr22 44324726 . T TG
    The flow cell evaluator say this is a insertion

    GT:AOP:FAO:FDP:FRO:FSAF:FSAR:FSRF:FSRR:GQ:RO:SAF:SAR:SRF:SRR
    1/1:5:27:27:27:0:16:11:0:0:11:22:0:5:16:6
    You see FSAF = 16, FSAR = 11, FSRF = 0, FSRR = 0, but the observations are

    SAF = 0, SAR=5, SRF=16, SRR=6

    if i look the alignment in IGV i see the following




    i check in dbSNP and in the position 44324727 a well known C/G snp 1KG MAF G=0.284 rs738409

    and the T variant at position 44324730 is also known rs738408



    So in my opinion is more likely a C/G rs738409 SNP, than a novel insertion, and even more it looks like a strand bias because the observed alternate allele as an insertion is only in the reverse strand.



    What's you opinion?
    Last edited by c_ro87; 10-03-2014, 06:51 AM.
  • lindenb
    Senior Member
    • Apr 2010
    • 143

    #2
    cross posted: https://www.biostars.org/p/114559/

    Comment

    • c_ro87
      Member
      • Feb 2012
      • 12

      #3
      how i delette this?

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Today, 02:55 AM
      0 responses
      6 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-24-2026, 12:17 PM
      0 responses
      11 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-23-2026, 11:41 AM
      0 responses
      12 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-20-2026, 11:10 AM
      0 responses
      24 views
      0 reactions
      Last Post SEQadmin2  
      Working...